Ovid Therapeutics Inc. Business Operations Contracts & Agreements

4 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Royalty, License and Termination Agreement, by and between the Company and Takeda Pharmaceutical Company Limited, dated March 2, 2021
Termination Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2021
Collaboration and License Agreement, by and between the Company and Angelini Pharma Rare Diseases AG, dated July 9, 2020
Collaboration Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2021
Collaboration and License Agreement, by and between the Company and Angelini Pharma Rare Diseases AG, dated July 9, 2020
Collaboration Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2020
LICENSE AND COLLABORATION AGREEMENT BY AND BETWEEN TAKEDAPHARMACEUTICAL COMPANY LIMITED AND OVID THERAPEUTICS INC. JANUARY 6, 2017 Table of Contents
Collaboration Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017